Christine Jenkins's Publications
About Christine Jenkins's Publications
Program Head, Respiratory- Professor of Respiratory Medicine, Faculty of Medicine, UNSW Sydney
- Clinical Professor, Concord Clinical School, University of Sydney
- AM,
- MD,
- FRACP,
- FThor ,
- Soc ,
- FAAHMS
-
Real-life effectiveness of omalizumab in severe allergic asthma above the recommended dosing range criteria
Clinical & Experimental Allergy Date published: -
Successes and challenges of COPD management in Australia: reflections on the past and future
The Lancet Respiratory Medicine Date published: -
Periostin levels and eosinophilic inflammation in poorly-controlled asthma
BMC Pulmonary Medicine Date published: -
AIRWAYS-ICPs (European Innovation Partnership on Active and Healthy Ageing) from concept to implementation
European Respiratory Journal Date published: -
Long-acting muscarinic antagonists: a potential add-on therapy in the treatment of asthma?
European Respiratory Review Date published: -
Early response to inhaled bronchodilators and corticosteroids as a predictor of 12-month treatment responder status and COPD exacerbations
International Journal of Chronic Obstructive Pulmonary Disease Date published: -
The Lung Microbiota In Stable Adult Asthma Differs According To Inflammatory Phenotype, Sex, And Atopy
Date published: -
Clinical Effectiveness Of Omalizumab In Severe Allergic Asthma Above The Recommended Dosing Range: The Australian Xolair Registry
Date published: -
THE LUNG MICROBIOTA IN STABLE ADULT ASTHMA DIFFERS ACCORDING TO INFLAMMATORY PHENOTYPE
Date published: -
CLINICAL EFFECTIVENESS OF OMALIZUMAB IN SEVERE ALLERGIC ASTHMA ABOVE THE STANDARD DOSING RANGE: THE AUSTRALIAN XOLAIR REGISTRY
Date published: -
SPUTUM INFLAMMATORY PHENOTYPES IN SYMPTOMATIC ASTHMA AROUND AUSTRALIA
Date published: -
PROVISION OF ONE-ON-ONE PATIENT EDUCATION AND COACHING OVER THE PHONE CAN IMPROVE ASTHMA CONTROL IN PEOPLE WITH ASTHMA
Date published: -
Reliever salbutamol use as a measure of exacerbation risk in chronic obstructive pulmonary disease
BMC Pulmonary Medicine Date published: -
Tuberculosis associates with both airflow obstruction and low lung function: BOLD results
European Respiratory Journal Date published: -
Development and validation of a novel risk score for asthma exacerbations: The risk score for exacerbations
Journal of Allergy and Clinical Immunology Date published: -
Efficacy of an inhaled corticosteroid/long-acting β2-agonist combination in symptomatic COPD patients in GOLD groups B and D
European Respiratory Journal Date published:
